Skip to main content
logo
Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.990
+0.010 (0.25%)
Feb 9, 2026, 12:30 PM EST - Market open

UPC Revenue

In the fiscal year ending September 30, 2025, Universe Pharmaceuticals INC had annual revenue of $17.86B, down -22.44%. Universe Pharmaceuticals INC had revenue of $8.92B in the half year ending September 30, 2025, with 175,929.82% growth.

Revenue (ttm)
$17.86B
Revenue Growth
-22.44%
P/S Ratio
0.10
Revenue / Employee
$82,679
Employees
216
Market Cap
2.25M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202517.86B-5.17B-22.44%
Sep 30, 202423.02B-9.28B-28.74%
Sep 30, 202332.31B32.27B80,383.80%
Sep 30, 202240.14M-7.84M-16.34%
Sep 30, 202147.98M17.28M56.27%
Sep 30, 202030.70M-2.53M-7.60%
Sep 30, 201933.23M4.72M16.54%
Sep 30, 201828.51M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
IM Cannabis37.61M
Sunshine Biopharma37.32M
Sonoma Pharmaceuticals16.94M
RedHill Biopharma9.55M
InMed Pharmaceuticals4.80M
China Pharma Holdings4.05M
China SXT Pharmaceuticals1.54M
Akanda836.66K
Revenue Rankings

UPC News

More News